-transparent.png){kind=logo}
Monoamine oxidase (MAO) is an important enzyme in the catabolism of brain biogenic amines. Platelet MAO has been reported to be moderately reduced in manic-depressive patients and markedly reduced in schizophrenic patients. This enzyme's activity has been shown to be under a large degree of genetic control and has been proposed as a 'genetic marker' in schizophrenia. A transcultural replication of the finding of low platelet MAO in schizophrenia and manic-depressive illness was carried out at the Jerusalem Mental Health Centre. Manic-depressive patients were found to have higher platelet MAO activity than schizophrenic patients, as reported previously, but control individuals were as low as the schizophrenic patients. It is unlikely that platelet MAO activity is a transculturally-valid marker for schizophrenia.
R H Belmaker, and
K Ebbesen, and
R Ebstein, and
R Rimon
July 1976,
Acta psychiatrica Scandinavica,
R H Belmaker, and
K Ebbesen, and
R Ebstein, and
R Rimon
January 1977,
Lancet (London, England),
R H Belmaker, and
K Ebbesen, and
R Ebstein, and
R Rimon
December 1970,
The American journal of psychiatry,
R H Belmaker, and
K Ebbesen, and
R Ebstein, and
R Rimon
October 1977,
Lancet (London, England),
R H Belmaker, and
K Ebbesen, and
R Ebstein, and
R Rimon
February 1979,
South Dakota journal of medicine,
R H Belmaker, and
K Ebbesen, and
R Ebstein, and
R Rimon
July 1975,
The American journal of psychiatry,
R H Belmaker, and
K Ebbesen, and
R Ebstein, and
R Rimon
January 1988,
Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952),
R H Belmaker, and
K Ebbesen, and
R Ebstein, and
R Rimon
January 1974,
Diseases of the nervous system,
R H Belmaker, and
K Ebbesen, and
R Ebstein, and
R Rimon
March 1980,
Archives of general psychiatry,
R H Belmaker, and
K Ebbesen, and
R Ebstein, and
R Rimon
October 1976,
The American journal of psychiatry,
